Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 11
Submit an article Journal homepage
1,614
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer

Ruirui WangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. China;Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Li YangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Chaoqi ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Ruijie WangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Zhen ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Qianyi HeBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Xinfeng ChenBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Bin ZhangDepartment of Hematology/Oncology, School of Medicine, Northwestern University, Chicago, IL60611, USAView further author information
,
Zhihai QinMedical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. ChinaView further author information
,
Liping WangCancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. ChinaCorrespondence[email protected]. [email protected].
View further author information
&
Yi ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450052, P.R. China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, P.R. China;School of Life Sciences, Zhengzhou University, Zhengzhou, Henan450001, P.R. ChinaCorrespondence[email protected]. [email protected].
View further author information
 show all
Article: e1461303 | Received 12 Dec 2017, Accepted 30 Mar 2018, Published online: 23 Aug 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.